WHO What’s New In Treatment Monitoring: Viral Load And CD4 Testing

HomeWHO What’s New In Treatment Monitoring: Viral Load And CD4 Testing

ART should be initiated in all children, adolescents, pregnant and breastfeeding women and adults living with HIV, regardless of WHO clinical stage and at any CD4 cell count.
ART should be initiated in all children, adolescents, pregnant and breastfeeding
women and adults living with HIV, regardless of WHO clinical stage and at any CD4 cell count.
As a priority, ART should be initiated in all children, adolescents and adults with severe or advanced HIV clinical disease and adults with a CD4 count ≤ 350 cells/mm3 as well as children < 5 years of age with WHO clinical stage 3 or 4 or CD4 count ≤ 750 cells/mm3.